Standards Comparison

    FDA 21 CFR Part 11

    Mandatory
    1997

    US FDA regulation for trustworthy electronic records and signatures

    VS

    FedRAMP

    Mandatory
    2011

    U.S. government framework standardizing federal cloud security authorization

    Quick Verdict

    FDA 21 CFR Part 11 ensures trustworthy electronic records for life sciences, while FedRAMP authorizes secure cloud services for federal agencies. Pharma firms adopt Part 11 for compliance; CSPs pursue FedRAMP to win government contracts.

    Electronic Records

    FDA 21 CFR Part 11

    21 CFR Part 11: Electronic Records; Electronic Signatures

    Cost
    €€€€
    Complexity
    Medium
    Implementation Time
    12-18 months

    Key Features

    • Equivalency criteria for electronic records to paper records
    • Secure, time-stamped audit trails for data integrity
    • Controls for closed and open system environments
    • Multi-component electronic signature requirements
    • Risk-based validation and enforcement discretion
    Cloud Security

    FedRAMP

    Federal Risk and Authorization Management Program

    Cost
    €€€
    Complexity
    Medium
    Implementation Time
    12-18 months

    Key Features

    • "Assess once, use many times" reusability model
    • NIST 800-53 Rev 5 controls at three impact levels
    • Independent third-party assessments by accredited 3PAOs
    • Ongoing continuous monitoring with monthly deliverables
    • FedRAMP Marketplace for authorized CSP visibility

    Detailed Analysis

    A comprehensive look at the specific requirements, scope, and impact of each standard.

    FDA 21 CFR Part 11 Details

    What It Is

    FDA 21 CFR Part 11 is a U.S. regulation establishing criteria for electronic records and electronic signatures to be trustworthy, reliable, and equivalent to paper records and handwritten signatures. It applies to FDA-regulated industries using electronic systems for predicate-rule records. The approach is risk-based, with narrow scope per 2003 FDA guidance, focusing on reliance on electronic records.

    Key Components

    • Subparts: General provisions, electronic records controls (§11.10 closed, §11.30 open systems), electronic signatures (§§11.50-11.300).
    • Core controls: validation, audit trails, access limits, operational/authority/device checks, training, accountability policies, signature linking/uniqueness.
    • Built on ALCOA+ principles for data integrity; no fixed control count, but enforced elements despite some discretion.

    Why Organizations Use It

    Mandatory for life sciences using electronic records to meet predicate rules; mitigates enforcement risks like warning letters. Enhances data integrity, inspection readiness, operational efficiency; builds stakeholder trust via non-repudiation.

    Implementation Overview

    Risk-based CSV lifecycle: scope records, GAMP categorization, IQ/OQ/PQ validation, SOPs/training. Applies to pharma/biotech/devices; no certification, but FDA inspection-enforced. Phased: gap analysis, vendor governance, change control.

    FedRAMP Details

    What It Is

    FedRAMP (Federal Risk and Authorization Management Program) is a U.S. government-wide framework standardizing security assessment, authorization, and continuous monitoring for cloud service offerings (CSOs) used by federal agencies. Its core purpose is "assess once, use many times," enabling reusable authorizations based on NIST SP 800-53 Rev 5 controls mapped to FIPS 199 impact levels (Low, Moderate, High).

    Key Components

    • **Baselines~150-410 controls by level (Low ~156, Moderate ~323, High ~410); LI-SaaS variant for low-risk SaaS.
    • Key artifacts: SSP, SAR, POA&M, continuous monitoring plans.
    • Relies on 3PAO independent assessments.
    • Paths: Agency or Program Authorization.

    Why Organizations Use It

    • Unlocks federal/state contracts ($20M+ potential).
    • Required for CMMC compliance in DoD work.
    • Mitigates risks, builds stakeholder trust.
    • Serves as security differentiator for commercial clients.

    Implementation Overview

    • 12-18 months typical: FIPS categorization, documentation, 3PAO assessment, ongoing monitoring.
    • Targets CSPs of all sizes pursuing government business.
    • No certification; requires sustained ATO via audits.

    Key Differences

    Scope

    FDA 21 CFR Part 11
    Electronic records/signatures trustworthiness
    FedRAMP
    Cloud service security assessment/monitoring

    Industry

    FDA 21 CFR Part 11
    Life sciences, pharma, medical devices
    FedRAMP
    Federal government cloud providers

    Nature

    FDA 21 CFR Part 11
    Mandatory FDA regulation with discretion
    FedRAMP
    Mandatory government-wide authorization program

    Testing

    FDA 21 CFR Part 11
    Risk-based system validation, audit trails
    FedRAMP
    3PAO assessments, continuous monitoring

    Penalties

    FDA 21 CFR Part 11
    Warning letters, enforcement actions
    FedRAMP
    Revocation of authorization, contract loss

    Frequently Asked Questions

    Common questions about FDA 21 CFR Part 11 and FedRAMP

    FDA 21 CFR Part 11 FAQ

    FedRAMP FAQ

    You Might also be Interested in These Articles...

    Run Maturity Assessments with GRADUM

    Transform your compliance journey with our AI-powered assessment platform

    Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

    100+ Standards & Regulations
    AI-Powered Insights
    Collaborative Assessments
    Actionable Recommendations

    Check out these other Gradum.io Standards Comparison Pages